Clarus initiated coverage of BZAM with a Speculative Buy rating and C$0.65 price target. Formerly The Green Organic Dutchman, the company, one of Canada’s "oldest and best-known" licensed producers of cannabis, substantially increased its product portfolio through an October 2022 merger with privately-held BZAM and sourced a billionaire backer who is now Chairman, the analyst tells investors. The firm calls this deal a "model merger" in the Canadian cannabis LP sector, given that two "sizable companies with limited product or geographic overlap" came together to drive economies of scale.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly